CavitySpace: A Database of Potential Ligand Binding Sites in the Human Proteome.
PMID:35883523
Unexpected similarity between HIV-1 reverse transcriptase and tumor necrosis factor binding sites revealed by computer vision.
PMID:34814950
2D SIFt: a matrix of ligand-receptor interactions.
PMID:34496955
Multiscale Simulations of SARS-CoV-2 3CL Protease Inhibition with Aldehyde Derivatives. Role of Protein and Inhibitor Conformational Changes in the Reaction Mechanism.
PMID:34192090
Resources and computational strategies to advance small molecule SARS-CoV-2 discovery: Lessons from the pandemic and preparing for future health crises.
PMID:33936562
A new microtubule-stabilizing agent shows potent antiviral effects against African swine fever virus with no cytotoxicity.
PMID:33706677
Three-Dimensional Convolutional Neural Networks and a Cross-Docked Data Set for Structure-Based Drug Design.
PMID:32865404
Synthesis, Optimization, Antifungal Activity, Selectivity, and CYP51 Binding of New 2-Aryl-3-azolyl-1-indolyl-propan-2-ols.
PMID:32784450
Unraveling Plant Natural Chemical Diversity for Drug Discovery Purposes.
PMID:32317969
visGReMLIN: graph mining-based detection and visualization of conserved motifs at 3D protein-ligand interface at the atomic level.
PMID:32164574
HIV-1 fusion inhibitors targeting the membrane-proximal external region of Env spikes.
PMID:32152540
Druggable exosites of the human kino-pocketome.
PMID:31925639
CavBench: A benchmark for protein cavity detection methods.
PMID:31609980
Macrocycle modeling in ICM: benchmarking and evaluation in D3R Grand Challenge 4.
PMID:31598897
Molecular Docking: Shifting Paradigms in Drug Discovery.
PMID:31487867
High Impact: The Role of Promiscuous Binding Sites in Polypharmacology.
PMID:31295958
Updates to Binding MOAD (Mother of All Databases): Polypharmacology Tools and Their Utility in Drug Repurposing.
PMID:31125569
Extended Multitarget Pharmacology of Anticancer Drugs.
PMID:31025863
2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 1. Identification of an Allosteric Binding Site.
PMID:30689953
Protein pocket detection via convex hull surface evolution and associated Reeb graph.
PMID:30423105
A benchmark driven guide to binding site comparison: An exhaustive evaluation using tailor-made data sets (ProSPECCTs).
PMID:30408032
GPCR homology model template selection benchmarking: Global versus local similarity measures.
PMID:30390544
Hybrid receptor structure/ligand-based docking and activity prediction in ICM: development and evaluation in D3R Grand Challenge 3.
PMID:30094533
SynPharm: A Guide to PHARMACOLOGY Database Tool for Designing Drug Control into Engineered Proteins.
PMID:30087931
Convolutional neural network scoring and minimization in the D3R 2017 community challenge.
PMID:29992528
Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions.
PMID:29848279
Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design.
PMID:29593527
Ranking Enzyme Structures in the PDB by Bound Ligand Similarity to Biological Substrates.
PMID:29551288
Convergence of Wnt, growth factor, and heterotrimeric G protein signals on the guanine nucleotide exchange factor Daple.
PMID:29487190
The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand.
PMID:29208933
Analysis of drug binding pockets and repurposing opportunities for twelve essential enzymes of ESKAPE pathogens.
PMID:28948099
Global organization of a binding site network gives insight into evolution and structure-function relationships of proteins.
PMID:28912495
Ligand-biased ensemble receptor docking (LigBEnD): a hybrid ligand/receptor structure-based approach.
PMID:28887659
Protein structural motifs in prediction and design.
PMID:28460216
Normal Modes Expose Active Sites in Enzymes.
PMID:28002427
Orphan receptor ligand discovery by pickpocketing pharmacological neighbors.
PMID:27992882
Emerging Computational Methods for the Rational Discovery of Allosteric Drugs.
PMID:27074285
Protein Ensembles: How Does Nature Harness Thermodynamic Fluctuations for Life? The Diverse Functional Roles of Conformational Ensembles in the Cell.
PMID:26807783
Historeceptomic Fingerprints for Drug-Like Compounds.
PMID:26733872
Structure-based predictions of activity cliffs.
PMID:25918827
Quantum Mechanics Approaches to Drug Research in the Era of Structural Chemogenomics.
PMID:25414519
Docking to multiple pockets or ligand fields for screening, activity prediction and scaffold hopping.
PMID:25407367
Assessing variation in the potential susceptibility of fish to pharmaceuticals, considering evolutionary differences in their physiology and ecology.
PMID:25405965
Recent improvements to Binding MOAD: a resource for protein-ligand binding affinities and structures.
PMID:25378330
sc-PDB: a 3D-database of ligandable binding sites--10 years on.
PMID:25300483
Drug-Like Protein-Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology.
PMID:25254076
Structure-based druggability assessment of the mammalian structural proteome with inclusion of light protein flexibility.
PMID:25079060
In silico identification and pharmacological evaluation of novel endocrine disrupting chemicals that act via the ligand-binding domain of the estrogen receptor α.
PMID:24928891
Towards structural systems pharmacology to study complex diseases and personalized medicine.
PMID:24830652
PLIC: protein-ligand interaction clusters.
PMID:24763918
PeptiSite: a structural database of peptide binding sites in 4D.
PMID:24406170
In silico analysis of the conservation of human toxicity and endocrine disruption targets in aquatic species.
PMID:24392850
ASD v2.0: updated content and novel features focusing on allosteric regulation.
PMID:24293647
A comprehensive survey of small-molecule binding pockets in proteins.
PMID:24204237
Molecular basis for benzodiazepine agonist action at the type 1 cholecystokinin receptor.
PMID:23754289
Pivotal role of P450-P450 interactions in CYP3A4 allostery: the case of α-naphthoflavone.
PMID:23651100
LISE: a server using ligand-interacting and site-enriched protein triangles for prediction of ligand-binding sites.
PMID:23609546
Pocket-based drug design: exploring pocket space.
PMID:23180158
Compound activity prediction using models of binding pockets or ligand properties in 3D.
PMID:23116466
Can the energy gap in the protein-ligand binding energy landscape be used as a descriptor in virtual ligand screening?
PMID:23071584
Small molecule inhibitors of Bacillus anthracis protective antigen proteolytic activation and oligomerization.
PMID:22954387
ALiBERO: evolving a team of complementary pocket conformations rather than a single leader.
PMID:22947092
Docking and scoring with ICM: the benchmarking results and strategies for improvement.
PMID:22569591